thecardiologyadvisor.com22h
Paxlovid Reduces COVID-19-Related Hospitalization, Death Through Day 28
Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.
ABC Action News8d
Newly FDA-approved COVID-19 treatment helps protect immunocompromised
OneBlood is the first blood center to get full FDA approval to give high-titer COVID-19 convalescent plasma to those with COVID-19 who are also immunocompromised.